Physician_Profile_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Record_ID,Nature_of_Payment_or_Transfer_of_Value,Name_of_Third_Party_Entity_Receiving_Payment_or_Transfer_of_Value,Name_of_Associated_Covered_Drug_or_Biological1,Name_of_Associated_Covered_Drug_or_Biological2,Contextual_Information
132783,"Boston Scientific Corporation",MA,100000005674,14317.00,12/10/2014,"Cash or cash equivalent",153121601,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,9722.31,12/10/2014,"Cash or cash equivalent",153121578,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,4800.00,10/07/2015,"Cash or cash equivalent",246017546,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Gilead Sciences Inc",CA,100000000108,4500.00,10/24/2015,"Cash or cash equivalent",310342246,Honoraria,"Cardiovascular Medicine PC",Ranexa,"","CMIND;Maddy Zamel20151113124516-11;Maddy Zamel20151113124516-11-11;10335212;VPL"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,4300.00,03/04/2015,"Cash or cash equivalent",260028704,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,4000.00,10/22/2015,"Cash or cash equivalent",290626510,"Consulting Fee","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3750.00,11/20/2013,"Cash or cash equivalent",104482766,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,3750.00,03/15/2015,"Cash or cash equivalent",260076044,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,09/08/2014,"Cash or cash equivalent",196536796,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,06/20/2014,"Cash or cash equivalent",196536818,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,3400.00,07/29/2014,"Cash or cash equivalent",196536810,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,08/26/2014,"Cash or cash equivalent",188042724,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,02/19/2014,"Cash or cash equivalent",187776134,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"Boston Scientific Corporation",MA,100000005674,3200.00,11/18/2015,"Cash or cash equivalent",246017508,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,3200.00,06/24/2015,"Cash or cash equivalent",246017538,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,3200.00,10/21/2015,"Cash or cash equivalent",246017550,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,01/07/2015,"Cash or cash equivalent",332309635,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,02/17/2015,"Cash or cash equivalent",332356459,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,3200.00,04/14/2015,"Cash or cash equivalent",332297041,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,3000.00,05/07/2014,"Cash or cash equivalent",164552628,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","627173-1680313-mzamel20140630075915-86-mzamel20140630075915-86-86-Gilead Sciences-VRL"
132783,"Gilead Sciences Inc",CA,100000000108,3000.00,02/09/2014,"Cash or cash equivalent",164830576,Honoraria,"Cardiovascular Medicine, PC",Ranexa,"","578166-1593788-mzamel20140310141146-12-mzamel20140310141146-12-12-Gilead Sciences-VRL"
132783,"Covidien Sales LLC",MA,100000000098,2800.00,11/13/2013,"Cash or cash equivalent",31676397,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Covidien Sales LLC",MA,100000000098,2800.00,10/06/2014,"Cash or cash equivalent",222035932,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Covidien Sales LLC",MA,100000000098,2800.00,01/06/2014,"Cash or cash equivalent",222035944,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,2800.00,07/29/2015,"Cash or cash equivalent",296920146,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,2800.00,07/17/2015,"Cash or cash equivalent",296297386,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine Pc","","",""
132783,"Covidien Sales LLC",MA,100000000098,2800.00,01/14/2015,"Cash or cash equivalent",295144728,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"The Medicines Company",NJ,100000010428,2750.00,10/11/2015,"Cash or cash equivalent",337737764,Honoraria,"",KENGREAL,"",""
132783,"LILLY USA, LLC",IN,100000000066,2700.00,11/15/2013,"Cash or cash equivalent",100181972,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"LILLY USA, LLC",IN,100000000066,2700.00,11/14/2013,"Cash or cash equivalent",100180838,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"LILLY USA, LLC",IN,100000000066,2700.00,09/25/2013,"Cash or cash equivalent",100180840,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2700.00,05/31/2014,"Cash or cash equivalent",196536924,"Consulting Fee","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boston Scientific Corporation",MA,100000005674,2560.00,12/17/2014,"Cash or cash equivalent",153121606,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,2560.00,12/10/2014,"Cash or cash equivalent",153121596,"Consulting Fee","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Pfizer Inc.",NY,100000000286,2500.00,10/27/2013,"Cash or cash equivalent",206077822,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Pfizer Inc.",NY,100000000286,2500.00,11/05/2014,"Cash or cash equivalent",207098460,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,12/14/2015,"Cash or cash equivalent",263310370,"Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program","CARDIOVASCULAR MEDICINE PC",ENTRESTO,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,11/18/2015,"Cash or cash equivalent",263310382,"Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program","CARDIOVASCULAR MEDICINE PC",ENTRESTO,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,2500.00,11/04/2015,"Cash or cash equivalent",263310386,"Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program","CARDIOVASCULAR MEDICINE PC",ENTRESTO,"",""
132783,"Covidien Sales LLC",MA,100000000098,2450.00,04/07/2014,"Cash or cash equivalent",222035934,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Covidien Sales LLC",MA,100000000098,2450.00,06/30/2014,"Cash or cash equivalent",222035942,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,07/15/2014,"Cash or cash equivalent",196536804,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,07/23/2014,"Cash or cash equivalent",196536812,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,10/29/2014,"Cash or cash equivalent",196011846,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,12/02/2015,"Cash or cash equivalent",290626518,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,12/02/2015,"Cash or cash equivalent",290626520,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2400.00,06/26/2015,"Cash or cash equivalent",290626528,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,11/25/2013,"Cash or cash equivalent",12196657,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,09/10/2013,"Cash or cash equivalent",12208432,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,05/14/2014,"Cash or cash equivalent",150031908,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,2150.00,06/18/2015,"Cash or cash equivalent",260113496,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,2050.00,12/17/2013,"Cash or cash equivalent",104481858,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,12/12/2013,"Cash or cash equivalent",100721636,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","563438-1569510-8024356-995765-20346314-995765-Gilead Sciences-"
132783,"Pfizer Inc.",NY,100000000286,2000.00,10/10/2013,"Cash or cash equivalent",205076410,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Pfizer Inc.",NY,100000000286,2000.00,10/10/2013,"Cash or cash equivalent",205206596,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Pfizer Inc.",NY,100000000286,2000.00,11/26/2013,"Cash or cash equivalent",205662100,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,02/18/2014,"Cash or cash equivalent",164552820,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","664742-1734997-8026401 - 1002651 - 20346314-1002651-Gilead Sciences-VRL"
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,07/28/2014,"Cash or cash equivalent",164552823,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","681931-1761910-8026402 - 1027377 - 20346314-1027377-Gilead Sciences-VRL"
132783,"Pfizer Inc.",NY,100000000286,2000.00,11/10/2014,"Cash or cash equivalent",206855624,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,04/25/2015,"Cash or cash equivalent",312643856,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine PC",Ranexa,"",CMIND;EHurry20150701155225-75;EHurry20150701155225-75-75;10335212;VPL
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,10/08/2015,"Cash or cash equivalent",312643870,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine PC",Ranexa,"","AHM;8042453 - 1081948 - 20346314;1081948;10335212;VPL"
132783,"Gilead Sciences Inc",CA,100000000108,2000.00,09/10/2015,"Cash or cash equivalent",312643878,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine PC",Ranexa,"","AHM;8042461 - 1077883 - 20346314;1077883;10335212;VPL"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1600.00,11/25/2013,"Cash or cash equivalent",12219409,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,1600.00,09/25/2013,"Cash or cash equivalent",12195294,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"Gilead Sciences Inc",CA,100000000108,1485.00,02/09/2014,"In-kind items and services",164853832,"Travel and Lodging","",Ranexa,"","633112-1689601-mzamel20140715084728-50-mzamel20140715084728-50-50-Gilead Sciences-VRL"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1300.00,06/20/2014,"Cash or cash equivalent",196536820,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Gilead Sciences Inc",CA,100000000108,960.00,11/16/2014,"Cash or cash equivalent",164830594,Honoraria,"Cardiovascular Medicine, PC","","","753477-1864319-mzamel20150104092737-7-mzamel20150104092737-7-7-Gilead Sciences-VRL"
132783,"Medrad Inc.",PA,100000005523,900.00,08/02/2013,"Cash or cash equivalent",31065789,"Consulting Fee","","","",""
132783,"LILLY USA, LLC",IN,100000000066,900.00,03/19/2014,"Cash or cash equivalent",137690096,"Consulting Fee","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"Thoratec Corporation",CA,100000000296,829.84,10/04/2013,"In-kind items and services",103186810,"Travel and Lodging","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,03/05/2014,"Cash or cash equivalent",187792876,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,02/21/2014,"Cash or cash equivalent",187779906,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,06/11/2014,"Cash or cash equivalent",187920274,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,810.00,05/06/2014,"Cash or cash equivalent",187878120,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,686.64,05/03/2014,"In-kind items and services",164853836,"Travel and Lodging","",Ranexa,"","757326-1868613-mzamel20150105135418-337-mzamel20150105135418-337-337-Gilead Sciences-VRL"
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,622.69,08/22/2013,"Cash or cash equivalent",101617588,"Travel and Lodging","","","",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,600.00,12/15/2015,"Cash or cash equivalent",263310378,"Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program","",ENTRESTO,"",""
132783,"Boston Scientific Corporation",MA,100000005674,593.23,12/10/2014,"Cash or cash equivalent",153121586,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,12/10/2013,"Cash or cash equivalent",13990607,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/04/2013,"Cash or cash equivalent",13990610,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/22/2013,"Cash or cash equivalent",13990603,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/26/2013,"Cash or cash equivalent",13990609,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,12/10/2013,"Cash or cash equivalent",13990604,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,10/14/2013,"Cash or cash equivalent",13990608,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/07/2013,"Cash or cash equivalent",13990605,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,10/03/2013,"Cash or cash equivalent",13990601,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,09/27/2013,"Cash or cash equivalent",13990602,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,585.00,11/25/2013,"Cash or cash equivalent",13990606,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,575.38,10/17/2015,"In-kind items and services",313991328,"Travel and Lodging","",Ranexa,"","CMIND;Kristen Anderson20160225165415-47;Kristen Anderson20160225165415-47-47;10335212;VPL"
132783,"Edwards Lifesciences Corporation",CA,100000010633,523.76,03/21/2014,"In-kind items and services",209055292,"Travel and Lodging","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,521.08,05/30/2014,"In-kind items and services",196536936,"Travel and Lodging","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,11/18/2014,"Cash or cash equivalent",196536930,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/23/2014,"Cash or cash equivalent",196536940,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,08/28/2014,"Cash or cash equivalent",196536946,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,11/17/2014,"Cash or cash equivalent",196536808,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/22/2014,"Cash or cash equivalent",196536938,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,500.00,09/11/2014,"Cash or cash equivalent",196536944,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,471.70,09/25/2015,"In-kind items and services",290626522,"Travel and Lodging","",PRADAXA,"",""
132783,"LILLY USA, LLC",IN,100000000066,450.00,12/27/2013,"Cash or cash equivalent",100180834,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"LILLY USA, LLC",IN,100000000066,450.00,08/23/2013,"Cash or cash equivalent",100181974,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"LILLY USA, LLC",IN,100000000066,450.00,11/10/2014,"Cash or cash equivalent",137697564,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"LILLY USA, LLC",IN,100000000066,450.00,12/12/2014,"Cash or cash equivalent",137695376,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"","THE REPORTED PAYMENT REFLECTS THE AMOUNT PROVIDED TO A THIRD PARTY EMPLOYER OR INSTITUTION IN CONNECTION WITH SERVICES PROVIDED BY THE COVERED RECIPIENT.  LILLY DOES NOT KNOW HOW MUCH, IF ANY, OF THIS AMOUNT WAS ACTUALLY RECEIVED BY THE COVERED RECIPIENT."
132783,"Thoratec Corporation",CA,100000000296,449.27,10/04/2013,"In-kind items and services",103186808,"Food and Beverage","","","","Multiple meals over multi-day education event - see Number of Payments"
132783,"Boston Scientific Corporation",MA,100000005674,431.25,04/07/2015,"Cash or cash equivalent",246017530,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,426.89,12/10/2014,"Cash or cash equivalent",153121582,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,424.70,03/13/2014,"In-kind items and services",209061606,"Travel and Lodging","","","",""
132783,"Medrad Inc.",PA,100000005523,400.00,08/02/2013,"Cash or cash equivalent",31048256,"Consulting Fee","","","",""
132783,"Medrad Inc.",PA,100000005523,400.00,08/02/2013,"Cash or cash equivalent",31071952,"Consulting Fee","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/14/2013,"Cash or cash equivalent",104477520,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/22/2013,"Cash or cash equivalent",104477522,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/17/2013,"Cash or cash equivalent",104477526,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/19/2013,"Cash or cash equivalent",104477530,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,08/20/2013,"Cash or cash equivalent",104477524,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,10/17/2013,"Cash or cash equivalent",104477534,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,11/22/2013,"Cash or cash equivalent",104477536,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,09/25/2013,"Cash or cash equivalent",104477528,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,375.00,10/15/2013,"Cash or cash equivalent",104477532,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"The Medicines Company",NJ,100000010428,346.19,10/11/2015,"In-kind items and services",337737766,"Food and Beverage","",KENGREAL,"",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,337.02,03/21/2014,"In-kind items and services",209043464,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,320.42,05/30/2014,"In-kind items and services",196536934,"Travel and Lodging","",PRADAXA,"",""
132783,"Boston Scientific Corporation",MA,100000005674,306.90,04/07/2015,"Cash or cash equivalent",246017528,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,300.52,02/25/2015,"In-kind items and services",260125204,"Travel and Lodging","",BRILINTA,"","Speaker Expenses"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,300.00,02/03/2015,"Cash or cash equivalent",260113640,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","",BRILINTA,"","Speaker Fee"
132783,"LILLY USA, LLC",IN,100000000066,269.00,12/23/2013,"Cash or cash equivalent",100181740,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Covidien Sales LLC",MA,100000000098,251.28,10/27/2013,"Cash or cash equivalent",31676395,"Food and Beverage","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,250.00,08/20/2013,"Cash or cash equivalent",14016068,"Consulting Fee","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,250.00,02/04/2014,"Cash or cash equivalent",164552624,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","591484-1616990-mzamel20140407085106-104-mzamel20140407085106-104-104-Gilead Sciences-VRL"
132783,"Gilead Sciences Inc",CA,100000000108,250.00,01/10/2014,"Cash or cash equivalent",164552620,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","Cardiovascular Medicine, PC",Ranexa,"","590964-1616272-mzamel20140407100300-83-mzamel20140407100300-83-83-Gilead Sciences-"
132783,"Gilead Sciences Inc",CA,100000000108,250.00,10/08/2014,"Cash or cash equivalent",164830596,Honoraria,"Cardiovascular Medicine, PC",Ranexa,"","778143-1898694-mzamel20150211080731-42-mzamel20150211080731-42-42-Gilead Sciences-VRL"
132783,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,200.00,02/19/2014,"Cash or cash equivalent",147742062,"Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program","CARDIOVASCULAR MEDICINE, PC",BYSTOLIC,"",""
132783,"Cardiovascular Systems Inc.",MN,100000000117,190.09,02/23/2015,"Cash or cash equivalent",318310482,"Food and Beverage","","","",""
132783,"LILLY USA, LLC",IN,100000000066,186.94,12/23/2013,"Cash or cash equivalent",100181978,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"AngioDynamics, Inc.",NY,100000005504,175.88,08/22/2014,"In-kind items and services",192798130,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,168.37,09/25/2015,"In-kind items and services",290626524,"Travel and Lodging","",PRADAXA,"",""
132783,"Biocompatibles, Inc.",CT,100000011081,167.72,10/10/2014,"In-kind items and services",220827968,"Food and Beverage","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,152.48,03/11/2014,"In-kind items and services",209064872,"Travel and Lodging","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,144.00,03/14/2014,"In-kind items and services",209043042,"Travel and Lodging","","","",""
132783,"AngioDynamics, Inc.",NY,100000005504,143.84,01/14/2015,"In-kind items and services",275731600,"Travel and Lodging","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,143.42,10/10/2014,"Cash or cash equivalent",215162210,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,140.74,07/17/2014,"In-kind items and services",153121632,"Food and Beverage","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,132.60,03/13/2014,"In-kind items and services",209058516,"Food and Beverage","","","",""
132783,"Daiichi Sankyo Inc.",NJ,100000000195,132.37,11/12/2013,"In-kind items and services",100742918,"Food and Beverage","",Effient,"",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,130.91,07/23/2015,"Cash or cash equivalent",317653780,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,128.93,09/20/2013,"Cash or cash equivalent",101619266,"Food and Beverage","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,128.53,09/21/2013,"In-kind items and services",101395618,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,125.57,11/12/2015,"Cash or cash equivalent",317664222,"Food and Beverage","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,125.42,11/19/2013,"In-kind items and services",28831661,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,125.00,05/30/2014,"In-kind items and services",196536822,"Food and Beverage","",PRADAXA,"",""
132783,"Boston Scientific Corporation",MA,100000005674,124.13,10/11/2015,"In-kind items and services",246017560,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,117.65,06/18/2015,"Cash or cash equivalent",317651662,"Food and Beverage","","","",""
132783,"Covidien Sales LLC",MA,100000000098,112.86,10/24/2014,"Cash or cash equivalent",222035940,"Food and Beverage","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,112.46,02/17/2015,"Cash or cash equivalent",332356463,"Travel and Lodging","",ELIQUIS,"",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,109.68,05/28/2015,"Cash or cash equivalent",317649972,"Food and Beverage","","","",""
132783,"Gilead Sciences Inc",CA,100000000108,109.10,11/16/2014,"In-kind items and services",168754494,"Food and Beverage","","","","778096-1898647-mgerson20150211075230-7-mgerson20150211075230-7-7-Gilead Sciences-VRL"
132783,"Edwards Lifesciences Corporation",CA,100000010633,108.70,09/16/2014,"In-kind items and services",209086656,"Food and Beverage","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,107.92,02/17/2015,"Cash or cash equivalent",332356453,"Food and Beverage","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,106.13,10/17/2015,"In-kind items and services",316682422,"Food and Beverage","",Ranexa,"","CMIND;Kristen Anderson20160225165415-28;Kristen Anderson20160225165415-28-28;10335212;VPL"
132783,"Thoratec Corporation",CA,100000000296,106.05,06/02/2015,"In-kind items and services",263748064,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,105.92,10/27/2015,"In-kind items and services",246017572,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.85,11/10/2015,"In-kind items and services",290626516,"Food and Beverage","",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,105.81,09/08/2014,"In-kind items and services",196011848,"Food and Beverage","",Pradaxa,"",""
132783,"Cardiovascular Systems Inc.",MN,100000000117,104.94,07/15/2015,"Cash or cash equivalent",318245128,"Travel and Lodging","","","",""
132783,"BOSTON SCIENTIFIC CORPORATION",MA,100000005674,102.29,11/11/2014,"In-kind items and services",227711002,"Food and Beverage","","","",""
132783,"AngioScore, Inc.",CA,100000010429,102.16,10/29/2013,"Cash or cash equivalent",102477196,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,101.68,12/17/2013,"In-kind items and services",104467782,"Food and Beverage","",Pradaxa,"",""
132783,"Merck Sharp & Dohme Corporation",NJ,100000000053,101.60,07/07/2015,"In-kind items and services",330667375,"Food and Beverage","",ZETIA,"",""
132783,"St. Jude Medical, Inc.",MN,100000000310,101.09,12/09/2013,"Cash or cash equivalent",100604578,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,100.00,01/17/2014,"In-kind items and services",148928324,"Food and Beverage","","","","Informational Meal"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,99.52,11/21/2013,"In-kind items and services",12205224,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
132783,"Gilead Sciences Inc",CA,100000000108,99.51,07/28/2014,"In-kind items and services",168754475,"Food and Beverage","",Ranexa,"","685097-1765076-8026402 - 1596737 - 20346314-1596737-Gilead Sciences-VRL"
132783,"Daiichi Sankyo Inc.",NJ,100000000195,99.20,11/25/2015,"In-kind items and services",326307612,"Food and Beverage","",Savaysa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,98.87,07/23/2014,"In-kind items and services",196536814,"Food and Beverage","",Pradaxa,"",""
132783,"Bayer HealthCare LLC",NJ,100000005409,98.16,04/01/2014,"In-kind items and services",218956204,"Food and Beverage","","","",""
132783,"Abbott Laboratories",IL,100000010680,96.77,09/14/2014,"In-kind items and services",195943246,"Food and Beverage","","","","AV AV 10380625 20141217 0005 AV 10380625 20141217 0005 0025"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,96.06,06/16/2015,"In-kind items and services",290626526,"Food and Beverage","",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,94.98,06/20/2014,"In-kind items and services",196536816,"Travel and Lodging","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"GENZYME CORPORATION",MA,100000000297,94.86,04/07/2014,"In-kind items and services",188523106,"Food and Beverage","",KYNAMRO,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,93.96,11/18/2015,"In-kind items and services",263310384,"Food and Beverage","",ENTRESTO,"",""
132783,"Bayer HealthCare LLC",NJ,100000005409,93.61,10/22/2013,"Cash or cash equivalent",31064516,"Food and Beverage","","","",""
132783,"The Medicines Company",NJ,100000010428,93.53,07/24/2014,"In-kind items and services",211978930,"Food and Beverage","",ANGIOMAX,"",""
132783,"LILLY USA, LLC",IN,100000000066,93.19,10/21/2013,"Cash or cash equivalent",100180842,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Abbott Laboratories",IL,100000010680,93.15,06/09/2015,"In-kind items and services",332938996,"Food and Beverage","","","","CTE84 31439620 4816274"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,92.93,05/08/2014,"In-kind items and services",148754632,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
132783,"Gilead Sciences Inc",CA,100000000108,92.02,09/17/2015,"In-kind items and services",316682416,"Food and Beverage","",Ranexa,"","AHM;8037660 - 1686854 - 20346314;1686854;10335212;VPL"
132783,"Gilead Sciences Inc",CA,100000000108,91.97,10/08/2015,"In-kind items and services",316682418,"Food and Beverage","",Ranexa,"","AHM;8042453 - 1775710 - 20346314;1775710;10335212;VPL"
132783,"Covidien Sales LLC",MA,100000000098,90.88,12/31/2013,"Cash or cash equivalent",31676398,"Food and Beverage","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,90.81,10/30/2013,"Cash or cash equivalent",31072894,"Food and Beverage","","","",""
132783,"Pfizer Inc.",NY,100000000286,90.27,10/29/2014,"In-kind items and services",207098458,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,88.86,11/20/2013,"In-kind items and services",104464782,"Travel and Lodging","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Covidien Sales LLC",MA,100000000098,87.16,09/24/2013,"Cash or cash equivalent",31676394,"Food and Beverage","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,86.86,05/14/2014,"In-kind items and services",219012268,"Food and Beverage","","","",""
132783,"Gilead Sciences Inc",CA,100000000108,85.69,11/18/2014,"In-kind items and services",168754478,"Food and Beverage","","","","730527-1829369-4893006-2572-Gilead Sciences-VRL"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,84.67,05/20/2015,"In-kind items and services",260126526,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
132783,"Cardiovascular Systems Inc.",MN,100000000117,84.62,03/04/2015,"Cash or cash equivalent",318259708,"Food and Beverage","","","",""
132783,"Thoratec Corporation",CA,100000000296,84.60,07/09/2015,"In-kind items and services",263748066,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,84.52,06/09/2015,"In-kind items and services",246017542,"Food and Beverage","","","",""
132783,"Merck Sharp & Dohme Corporation",NJ,100000000053,84.10,02/18/2015,"In-kind items and services",331204221,"Food and Beverage","",ZONTIVITY,"",""
132783,"St. Jude Medical, Inc.",MN,100000000310,83.70,01/13/2014,"Cash or cash equivalent",164817722,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,82.74,09/25/2015,"In-kind items and services",290626508,"Food and Beverage","",PRADAXA,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,82.58,04/14/2015,"Cash or cash equivalent",332297045,"Travel and Lodging","",ELIQUIS,"",""
132783,"Boston Scientific Corporation",MA,100000005674,82.05,04/16/2015,"In-kind items and services",246017534,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,81.99,10/01/2014,"Cash or cash equivalent",215160952,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,81.99,10/01/2014,"Cash or cash equivalent",215160948,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,81.29,07/27/2015,"In-kind items and services",246017520,"Food and Beverage","","","",""
132783,"Cordis Corporation",CA,100000005411,80.57,06/02/2014,"In-kind items and services",120486081,"Food and Beverage","","","","Related to product discussion"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,79.80,09/08/2014,"In-kind items and services",196536798,"Travel and Lodging","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boston Scientific Corporation",MA,100000005674,79.47,09/29/2015,"In-kind items and services",246017568,"Food and Beverage","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,78.75,08/12/2013,"In-kind items and services",101395614,"Food and Beverage","","","",""
132783,"Abbott Laboratories",IL,100000010680,78.18,10/12/2014,"In-kind items and services",195947952,"Food and Beverage","","","","CTE84 26610078 4816274"
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,77.94,06/11/2015,"In-kind items and services",263310374,"Food and Beverage","",ENTRESTO,"",""
132783,"Gilead Sciences Inc",CA,100000000108,77.81,02/18/2014,"In-kind items and services",164853834,"Travel and Lodging","",Ranexa,"","664743-1734998-8026401 - 1002295 - 20346314-1002295-Gilead Sciences-VRL"
132783,"Medtronic Vascular, Inc.",MN,100000010384,77.02,11/19/2015,"In-kind items and services",296297382,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,76.66,12/09/2014,"In-kind items and services",153121617,"Food and Beverage","","","",""
132783,"Pfizer Inc.",NY,100000000286,76.47,10/11/2013,"In-kind items and services",205076438,"Food and Beverage","",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,76.18,08/26/2014,"Cash or cash equivalent",188044346,"Food and Beverage","",ELIQUIS,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,75.79,11/04/2015,"Cash or cash equivalent",263310380,"Travel and Lodging","",ENTRESTO,"",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,75.40,05/29/2014,"In-kind items and services",209069572,"Food and Beverage","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,73.86,10/28/2013,"In-kind items and services",101395612,"Food and Beverage","","","",""
132783,"EMD Serono, Inc.",MA,100000000127,72.96,07/23/2014,"Cash or cash equivalent",209083052,"Food and Beverage","",Gonal-f,"",""
132783,"Boston Scientific Corporation",MA,100000005674,70.09,10/15/2014,"In-kind items and services",153121693,"Food and Beverage","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,69.51,01/07/2015,"Cash or cash equivalent",332309627,"Food and Beverage","",ELIQUIS,"",""
132783,"Regeneron Pharmaceuticals, Inc.",NY,100000000069,69.33,08/25/2015,"In-kind items and services",321527749,"Food and Beverage","","PRALUENT (alirocumab) Injection","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,69.00,05/31/2014,"In-kind items and services",196536926,"Travel and Lodging","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boston Scientific Corporation",MA,100000005674,68.50,04/08/2015,"In-kind items and services",246017536,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,67.61,11/16/2015,"In-kind items and services",246017516,"Food and Beverage","","","",""
132783,"LILLY USA, LLC",IN,100000000066,67.40,09/25/2013,"In-kind items and services",100161862,"Food and Beverage","",EFFIENT,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,65.30,02/25/2015,"In-kind items and services",260124902,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,65.03,04/14/2015,"Cash or cash equivalent",332297021,"Food and Beverage","",ELIQUIS,"",""
132783,"St. Jude Medical, Inc.",MN,100000000310,64.89,03/09/2015,"Cash or cash equivalent",259521018,"Food and Beverage","","","",""
132783,"ZOLL Lifecor Corporation",PA,100000000178,64.60,10/10/2013,"In-kind items and services",103996434,"Food and Beverage","","","",""
132783,"Pfizer Inc.",NY,100000000286,64.58,10/24/2014,"In-kind items and services",207098462,"Food and Beverage","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,64.21,12/12/2013,"In-kind items and services",102129486,"Food and Beverage","",Ranexa,"","563437-1569509-8024356-1529521-20346314-1529521-Gilead Sciences"
132783,"Bayer HealthCare LLC",NJ,100000005409,64.09,08/06/2014,"In-kind items and services",219052964,"Food and Beverage","","","",""
132783,ABIOMED,MA,100000010740,64.06,08/04/2015,"In-kind items and services",337563260,"Food and Beverage","","","",""
132783,"Thoratec Corporation",CA,100000000296,64.00,11/04/2013,"In-kind items and services",103186806,"Food and Beverage","","","",""
132783,"Pfizer Inc.",NY,100000000286,61.72,10/18/2013,"In-kind items and services",206077818,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,61.22,02/18/2014,"In-kind items and services",168754490,"Food and Beverage","",Ranexa,"","772557-1892629-8026401 - 1545273 - 20346314-1545273-Gilead Sciences-VRL"
132783,"Covidien Sales LLC",MA,100000000098,60.57,01/19/2014,"Cash or cash equivalent",222035936,"Food and Beverage","","","",""
132783,"Gilead Sciences Inc",CA,100000000108,60.43,05/03/2014,"In-kind items and services",168754488,"Food and Beverage","",Ranexa,"","757236-1868523-mzamel20150105135418-247-mzamel20150105135418-247-247-Gilead Sciences-VRL"
132783,"Boston Scientific Corporation",MA,100000005674,59.19,09/16/2014,"In-kind items and services",153121680,"Food and Beverage","","","",""
132783,"Gilead Sciences Inc",CA,100000000108,58.19,02/09/2014,"In-kind items and services",168754468,"Food and Beverage","",Ranexa,"","633091-1689580-mzamel20140715084728-29-mzamel20140715084728-29-29-Gilead Sciences-VRL"
132783,"Lantheus Medical Imaging, Inc.",MA,100000005400,58.06,03/05/2014,"In-kind items and services",182165486,"Food and Beverage","",Definity,"",""
132783,"Boston Scientific Corporation",MA,100000005674,57.57,12/10/2014,"Cash or cash equivalent",153121590,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Boston Scientific Corporation",MA,100000005674,51.98,10/14/2014,"In-kind items and services",153121686,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,51.59,07/29/2014,"In-kind items and services",196536942,"Food and Beverage","",Pradaxa,"",""
132783,"Gilead Sciences Inc",CA,100000000108,50.00,04/25/2015,"In-kind items and services",316682412,"Food and Beverage","",Ranexa,"","CMIND;Kristen Petitto20150828151919-154;Kristen Petitto20150828151919-154-154;10335212;VPL"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,49.66,11/20/2013,"In-kind items and services",104460112,"Food and Beverage","",Pradaxa,"",""
132783,"Gilead Sciences Inc",CA,100000000108,49.54,05/03/2014,"In-kind items and services",168754482,"Food and Beverage","",Ranexa,"","757115-1868402-mzamel20150105135418-126-mzamel20150105135418-126-126-Gilead Sciences-VRL"
132783,"Gilead Sciences Inc",CA,100000000108,49.40,02/09/2014,"In-kind items and services",168754471,"Food and Beverage","",Ranexa,"","633092-1689581-mzamel20140715084728-30-mzamel20140715084728-30-30-Gilead Sciences-VRL"
132783,"Gilead Sciences Inc",CA,100000000108,48.22,10/17/2015,"In-kind items and services",316682420,"Food and Beverage","",Ranexa,"","CMIND;Kristen Anderson20160225165415-29;Kristen Anderson20160225165415-29-29;10335212;VPL"
132783,"Gilead Sciences Inc",CA,100000000108,48.18,04/25/2015,"In-kind items and services",316682414,"Food and Beverage","",Ranexa,"","CMIND;Kristen Petitto20150828151919-68;Kristen Petitto20150828151919-68-68;10335212;VPL"
132783,"Pfizer Inc.",NY,100000000286,47.28,10/22/2013,"In-kind items and services",206077806,"Food and Beverage","",ELIQUIS,"",""
132783,"Gilead Sciences Inc",CA,100000000108,47.24,10/28/2013,"In-kind items and services",102129484,"Food and Beverage","",Ranexa,"","560908-1566649-mzamel20140202102503-8-mzamel20140202102503-8-8-Gilead Sciences"
132783,"EKOS Corporation",WA,100000011032,46.60,12/02/2013,"Cash or cash equivalent",105370554,Education,"","","",""
132783,"Gilead Sciences Inc",CA,100000000108,46.59,10/17/2015,"In-kind items and services",316682426,"Food and Beverage","",Ranexa,"","CMIND;Kristen Anderson20160225165415-30;Kristen Anderson20160225165415-30-30;10335212;VPL"
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,46.35,12/14/2015,"Cash or cash equivalent",263310368,"Travel and Lodging","",ENTRESTO,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,46.31,07/15/2014,"In-kind items and services",196536802,"Travel and Lodging","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,46.00,02/11/2015,"Cash or cash equivalent",317639956,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,45.83,07/15/2014,"In-kind items and services",196536806,"Food and Beverage","",Pradaxa,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,45.20,09/23/2013,"In-kind items and services",12209496,"Travel and Lodging","",BRILINTA,"","Speaker Expenses"
132783,"Cardiovascular Systems Inc.",MN,100000000117,44.46,09/23/2013,"Cash or cash equivalent",101762124,"Food and Beverage","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,43.57,04/01/2014,"In-kind items and services",209064692,"Travel and Lodging","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,42.80,09/19/2013,"Cash or cash equivalent",31076239,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,42.26,09/25/2015,"In-kind items and services",290626506,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,05/31/2014,"In-kind items and services",196536916,"Food and Beverage","",PRADAXA,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,40.00,02/25/2015,"In-kind items and services",260120416,"Travel and Lodging","",BRILINTA,"","Speaker Expenses"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,09/26/2015,"In-kind items and services",290626502,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,40.00,09/26/2015,"In-kind items and services",290626514,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,36.81,05/31/2014,"In-kind items and services",196536928,"Food and Beverage","Midwest Cardiovascular Research Foundation",Pradaxa,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,35.00,09/26/2015,"In-kind items and services",290626534,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,34.99,05/31/2014,"In-kind items and services",196536824,"Food and Beverage","",PRADAXA,"",""
132783,"LILLY USA, LLC",IN,100000000066,32.28,12/23/2013,"Cash or cash equivalent",100180868,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,31.51,03/06/2014,"In-kind items and services",216397558,"Food and Beverage","",SAMSCA,"",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,30.05,11/04/2015,"In-kind items and services",263310376,"Food and Beverage","",ENTRESTO,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,29.99,09/26/2015,"In-kind items and services",290626530,"Food and Beverage","",PRADAXA,"",""
132783,"Boston Scientific Corporation",MA,100000005674,29.65,04/07/2015,"Cash or cash equivalent",246017526,"Food and Beverage","CARDIOVASCULAR MEDICINE PC","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,27.61,12/14/2015,"In-kind items and services",310754084,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,27.49,10/16/2014,"In-kind items and services",153121699,"Food and Beverage","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,26.67,12/19/2013,"In-kind items and services",101395620,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,26.25,10/28/2015,"In-kind items and services",246017574,"Food and Beverage","","","",""
132783,"Regeneron Healthcare Solutions, Inc.",NY,100000136416,25.76,07/30/2015,"In-kind items and services",321524884,"Food and Beverage","","PRALUENT (alirocumab) Injection","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.99,05/31/2014,"In-kind items and services",196536914,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,24.99,05/31/2014,"In-kind items and services",196536826,"Food and Beverage","",PRADAXA,"",""
132783,"Gilead Sciences Inc",CA,100000000108,24.68,09/10/2015,"In-kind items and services",316682424,"Food and Beverage","",Ranexa,"","AHM;8042461 - 1760913 - 20346314;1760913;10335212;VPL"
132783,"Cordis Corporation",CA,100000005411,22.16,10/07/2013,"In-kind items and services",10402253,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,21.92,02/06/2014,"In-kind items and services",149097264,"Food and Beverage","",BRILINTA,"","Informational Meal"
132783,"Cordis Corporation",CA,100000005411,21.70,11/07/2013,"In-kind items and services",10403306,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,21.40,09/30/2014,"In-kind items and services",153121704,"Food and Beverage","","","",""
132783,"Cordis Corporation",CA,100000005411,21.37,08/28/2013,"In-kind items and services",10401450,"Food and Beverage","","","",""
132783,"LILLY USA, LLC",IN,100000000066,21.20,12/23/2013,"Cash or cash equivalent",100180866,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Bayer HealthCare LLC",NJ,100000005409,19.88,10/23/2013,"Cash or cash equivalent",31071002,"Food and Beverage","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,19.88,10/23/2013,"Cash or cash equivalent",31058491,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,19.81,09/26/2015,"In-kind items and services",290626504,"Food and Beverage","",PRADAXA,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,19.56,02/19/2014,"Cash or cash equivalent",187777448,"Food and Beverage","",ELIQUIS,"",""
132783,"Cook Incorporated",IN,100000010458,19.23,12/04/2013,"Cash or cash equivalent",210737320,"Food and Beverage","","","","Physicians are provided modest meals during the course of doing business with Cook Medical. The physician could be attending or presenting at an educational presentation or a product training session. We also invite physicians to dinners to give us feedback on our products or to advise us on trends in medical procedures and treatments. The total cost of a group's food and beverages at a meal are averaged across attendees."
132783,"Bayer HealthCare LLC",NJ,100000005409,19.07,04/02/2014,"In-kind items and services",218959514,"Food and Beverage","","","",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,19.06,01/12/2015,"In-kind items and services",296920142,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,18.00,10/12/2015,"In-kind items and services",246017564,"Food and Beverage","","","",""
132783,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,17.94,11/19/2013,"In-kind items and services",105126726,"Food and Beverage","",SAMSCA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.94,12/01/2015,"In-kind items and services",290626532,"Food and Beverage","",JARDIANCE,"",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,17.85,06/17/2014,"In-kind items and services",209052542,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,17.40,12/10/2014,"In-kind items and services",153121626,"Food and Beverage","","","",""
132783,"Edwards Lifesciences Corporation",CA,100000010633,17.29,06/08/2015,"In-kind items and services",310639929,"Food and Beverage","","","",""
132783,"BOSTON SCIENTIFIC CORPORATION",MA,100000005674,16.81,11/13/2014,"In-kind items and services",227711004,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,16.76,12/10/2014,"In-kind items and services",153121622,"Food and Beverage","","","",""
132783,"Otsuka America Pharmaceutical, Inc.",MD,100000010723,16.56,10/17/2013,"In-kind items and services",105126724,Education,"","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.29,08/06/2013,"In-kind items and services",12205369,"Food and Beverage","",BRILINTA,"","Informational Meal"
132783,"Cardiovascular Systems Inc.",MN,100000000117,16.24,12/10/2013,"Cash or cash equivalent",101766826,"Food and Beverage","","","",""
132783,"Bard Peripheral Vascular, Inc.",AZ,100000005481,16.14,11/20/2013,"Cash or cash equivalent",101622902,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.01,03/24/2015,"In-kind items and services",260066574,"Food and Beverage","",BRILINTA,FARXIGA,"Informational Meal"
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,15.89,10/29/2014,"In-kind items and services",196536932,"Food and Beverage","",Pradaxa,"",""
132783,"Boston Scientific Corporation",MA,100000005674,15.58,09/30/2015,"In-kind items and services",246017570,"Food and Beverage","","","",""
132783,"Daiichi Sankyo Inc.",NJ,100000000195,15.50,02/19/2014,"In-kind items and services",199573690,"Food and Beverage","",Effient,"",""
132783,"Covidien Sales LLC",MA,100000000098,15.40,09/18/2013,"Cash or cash equivalent",31676396,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.31,09/23/2013,"In-kind items and services",174056110,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.21,03/04/2014,"In-kind items and services",149343560,"Food and Beverage","",BRILINTA,"","Informational Meal"
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,15.20,11/10/2015,"In-kind items and services",263310388,"Food and Beverage","",ENTRESTO,"",""
132783,"AngioDynamics, Inc.",NY,100000005504,14.07,01/23/2015,"In-kind items and services",270276218,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,14.06,06/10/2015,"In-kind items and services",246017544,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.62,06/20/2014,"In-kind items and services",196536800,"Food and Beverage","",Pradaxa,"",""
132783,"Bayer HealthCare LLC",NJ,100000005409,13.61,09/11/2013,"Cash or cash equivalent",31073594,"Food and Beverage","","","",""
132783,"Daiichi Sankyo Inc.",NJ,100000000195,13.15,10/22/2014,"In-kind items and services",199573686,"Food and Beverage","",Effient,"",""
132783,"Lantheus Medical Imaging, Inc.",MA,100000005400,12.60,12/15/2015,"In-kind items and services",265077696,"Food and Beverage","",Definity,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.59,11/21/2013,"In-kind items and services",12192835,"Travel and Lodging","",BRILINTA,"","Speaker Expenses"
132783,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.55,09/14/2015,"In-kind items and services",337328214,"Food and Beverage","",Contrave,"",""
132783,"Pfizer Inc.",NY,100000000286,12.49,10/03/2013,"In-kind items and services",205206612,"Food and Beverage","",ELIQUIS,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.28,06/11/2014,"In-kind items and services",196536912,"Food and Beverage","",PRADAXA,"",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.13,11/09/2015,"In-kind items and services",290140358,"Food and Beverage","",Pradaxa,"",""
132783,"Medtronic Vascular, Inc.",MN,100000010384,12.11,09/21/2013,"In-kind items and services",101395616,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.91,11/21/2013,"In-kind items and services",12288160,"Travel and Lodging","",BRILINTA,"","Speaker Expenses"
132783,"Medtronic Vascular, Inc.",MN,100000010384,11.64,02/17/2015,"In-kind items and services",296920144,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,11.59,10/05/2015,"In-kind items and services",246017552,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.57,09/16/2013,"In-kind items and services",12260694,"Food and Beverage","",SYMBICORT,"","Informational Meal"
132783,"Pfizer Inc.",NY,100000000286,11.55,11/07/2014,"In-kind items and services",206855630,"Food and Beverage","",ELIQUIS,"",""
132783,"Pfizer Inc.",NY,100000000286,11.43,11/19/2013,"In-kind items and services",205662126,"Food and Beverage","",ELIQUIS,"",""
132783,"Boston Scientific Corporation",MA,100000005674,11.42,03/11/2015,"In-kind items and services",246017532,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,10.60,09/16/2015,"In-kind items and services",246017556,"Food and Beverage","","","",""
132783,"Lantheus Medical Imaging, Inc.",MA,100000005400,10.50,08/23/2013,"In-kind items and services",101635330,"Food and Beverage","",Definity,"",""
132783,"Covidien Sales LLC",MA,100000000098,10.49,09/10/2014,"Cash or cash equivalent",222035938,"Food and Beverage","","","",""
132783,"Cordis Corporation",CA,100000005411,10.46,04/01/2015,"In-kind items and services",247139596,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.00,02/13/2014,"In-kind items and services",148305652,Education,"",BRILINTA,"","Journal Article"
132783,"The Medicines Company",NJ,100000010428,9.99,08/06/2015,"In-kind items and services",337737734,"Food and Beverage","",KENGREAL,"",""
132783,"Daiichi Sankyo Inc.",NJ,100000000195,8.82,11/12/2013,"In-kind items and services",100742916,"Food and Beverage","",Effient,"",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,8.63,09/16/2013,"In-kind items and services",12288159,"Food and Beverage","",SYMBICORT,"","Informational Meal"
132783,"Boston Scientific Corporation",MA,100000005674,8.36,11/24/2015,"In-kind items and services",246017512,"Food and Beverage","","","",""
132783,"LILLY USA, LLC",IN,100000000066,8.00,12/23/2013,"Cash or cash equivalent",100180836,"Travel and Lodging","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Cardiovascular Systems Inc.",MN,100000000117,7.63,07/23/2014,"Cash or cash equivalent",204284374,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,7.50,06/04/2014,"In-kind items and services",153121674,"Food and Beverage","","","",""
132783,"NOVARTIS PHARMACEUTICALS CORPORATION",NJ,100000000228,7.25,12/14/2015,"In-kind items and services",263310372,"Food and Beverage","",ENTRESTO,"",""
132783,"Pfizer Inc.",NY,100000000286,6.78,10/03/2013,"In-kind items and services",205206614,"Travel and Lodging","CARDIOVASCULAR MEDICINE PC",ELIQUIS,"",""
132783,"AngioScore, Inc.",CA,100000010429,6.33,12/11/2013,"Cash or cash equivalent",102477194,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,6.00,05/14/2014,"In-kind items and services",153121668,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,6.00,08/25/2014,"In-kind items and services",153121636,"Food and Beverage","","","",""
132783,"The Medicines Company",NJ,100000010428,5.16,08/25/2015,"In-kind items and services",337737736,"Food and Beverage","",KENGREAL,"",""
132783,"LILLY USA, LLC",IN,100000000066,5.00,12/23/2013,"Cash or cash equivalent",100181976,"Food and Beverage","CARDIOVASCULAR MEDICINE, PC",EFFIENT,"",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,04/11/2014,"In-kind items and services",153121646,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,04/24/2014,"In-kind items and services",153121651,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,04/25/2014,"In-kind items and services",153121656,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,03/05/2014,"In-kind items and services",153121642,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,05/01/2014,"In-kind items and services",153121662,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,11/21/2014,"In-kind items and services",153121612,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,5.00,11/03/2015,"In-kind items and services",246017514,"Food and Beverage","","","",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,4.41,08/07/2013,"Cash or cash equivalent",14016070,Education,"",ELIQUIS,"",""
132783,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,4.41,08/07/2013,"Cash or cash equivalent",14016069,Education,"",ELIQUIS,"",""
132783,"Cordis Corporation",CA,100000005411,3.91,01/14/2015,"In-kind items and services",247137324,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,3.47,08/26/2015,"In-kind items and services",246017518,"Food and Beverage","","","",""
132783,"Boston Scientific Corporation",MA,100000005674,2.46,06/02/2015,"In-kind items and services",246017540,"Food and Beverage","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,2.31,09/11/2013,"Cash or cash equivalent",31072042,"Food and Beverage","","","",""
132783,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.31,12/02/2015,"In-kind items and services",331116649,"Food and Beverage","",ZONTIVITY,"",""
132783,"Cardiovascular Systems Inc.",MN,100000000117,1.94,09/25/2013,"Cash or cash equivalent",101762324,"Food and Beverage","","","",""
132783,"Bayer HealthCare LLC",NJ,100000005409,1.89,09/11/2013,"Cash or cash equivalent",31058311,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,"In-kind items and services",196536920,Education,"",APTIVUS,VIRAMUNE,""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,"In-kind items and services",196536918,Education,"",APTIVUS,VIRAMUNE,""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.88,04/01/2014,"In-kind items and services",196536922,Education,"",APTIVUS,VIRAMUNE,""
132783,"Cardiovascular Systems Inc.",MN,100000000117,1.86,12/16/2013,"Cash or cash equivalent",101759012,"Food and Beverage","","","",""
132783,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,11/17/2015,"In-kind items and services",290626512,Education,"",JARDIANCE,"",""
132783,"Bayer HealthCare LLC",NJ,100000005409,1.42,09/11/2013,"Cash or cash equivalent",31075061,"Food and Beverage","","","",""
132783,"Cardiovascular Systems Inc.",MN,100000000117,1.33,12/18/2013,"Cash or cash equivalent",101759082,"Food and Beverage","","","",""
132783,"AstraZeneca Pharmaceuticals LP",DE,100000000146,0.62,09/23/2013,"In-kind items and services",174059024,"Food and Beverage","",BRILINTA,"","Speaker Expenses"
